Potent, Selective CARs as Potential T-Cell Therapeutics for HPV-positive Cancers

MLA

Kathleen R Negri, et al. “Potent, Selective CARs as Potential T-Cell Therapeutics for HPV-Positive Cancers.” Journal of Immunotherapy, vol. 44, Aug. 2021, pp. 292–306. EBSCOhost, https://doi.org/10.1097/cji.0000000000000386.

APA

Kathleen R Negri, Xueyin Wang, Han Xu, Mark E. Daris, Aaron D. Martin, Craig Pigott, Falene Chai, Christine Yao, Ming-Lun Wu, James Furney, Dora Toledo Warshaviak, Grant B Gabrelow, Daniel P Nampe, Mark L. Sandberg, Alexander Kamb, Wen-Hua Lee, Julyun Oh, & Michele McElvain. (2021). Potent, Selective CARs as Potential T-Cell Therapeutics for HPV-positive Cancers. Journal of Immunotherapy, 44, 292–306. https://doi.org/10.1097/cji.0000000000000386

Chicago

Kathleen R Negri, Xueyin Wang, Han Xu, Mark E. Daris, Aaron D. Martin, Craig Pigott, Falene Chai, et al. 2021. “Potent, Selective CARs as Potential T-Cell Therapeutics for HPV-Positive Cancers.” Journal of Immunotherapy 44 (August): 292–306. doi:10.1097/cji.0000000000000386.